ClinicalTrials.govpublic full text
Safety of RAD001 in Chinese Patients With Metastatic Renal Cell Cancer
metastatic renal cell carcinoma, mrcc,, everolimus,, mtor,, intolerant of vegf-therapies, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 969025
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.